The Finecare™ CEA Rapid Quantitative Test is a fluorescence immunoassay used along with Finecare™ FIA System for quantitative determination of carcino-embryonic antigen in human whole blood, serum or plasma. The test is used as an aid in the evaluation of therapeutic efficiency, prognosis and recurrence monitoring for carcinoma.